February 16, 2017

Baker-Polito Administration Awards $3 Million to the Gloucester Marine Genomics Institute and North Shore Schools

Governor Charlie Baker announced a total of $3 million in capital grant funding for the Gloucester Marine Genomics Institute, and for middle and high schools in Gloucester, Lynn, and Salem. The grants, from the Massachusetts Life Sciences Center, advance the Baker-Polito Administration’s commitment to build a highly trained workforce and seed job creation in regions across Massachusetts.

Read the press release here.


MLSC President & CEO Travis McCready, Gloucester Mayor Sefatia Romeo Theken, and Governor Baker observe a demonstration genetic experiment led by GMGI Associate Scientist Marc Gasser involving a large cod at the Gloucester Marine Genomics institute.
January 31, 2017

Massachusetts Life Sciences Center Announces Launch of Massachusetts Ramp-Up Program

The Massachusetts Life Sciences Center (MLSC) announced today the launch of the Massachusetts Ramp-Up Program (MassRamp), a new program that will provide grant funding to promising early-stage life sciences companies. The program will provide supplemental grant funding, on a competitive basis, to companies that have been awarded Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) Phase I grants or contracts from federal agencies. MassRamp aims to bridge the funding gaps associated with the long life sciences R&D cycle, and the high cost of translating research into commercially viable products.  Up to $3,000,000 in funding is available for this inaugural round of the program.

Read the press release here.

January 19, 2017

Science from Scientists Empowers Revere Public Schools with Support of Massachusetts Life Sciences Center

Science from Scientists (SfS), a non-profit dedicated to ensuring our nation’s youth are competitive globally in STEM fields, announced that they have been awarded a $50,000 grant from the Massachusetts Life Sciences Center (MLSC) to further support their mission.

Read the press release here.

January 5, 2017

Massachusetts Life Sciences Center Announces Opening of Life Sciences Tax Incentive Program

The Massachusetts Life Sciences Center (MLSC) announced today that applications are now being accepted for a new round of the Center’s Tax Incentive Program. The Program offers tax incentives to encourage the growth of companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts. The MLSC will again seek to leverage the life sciences assets that are in place around the state, and utilize the Tax Incentive Program to promote growth throughout Massachusetts. Toward that end, the agency is actively encouraging applications from companies located outside of Greater Boston.  The MLSC is also encouraging participation by first-time applicants, minority and women-run businesses, and companies engaged in manufacturing.

Read the press release here

January 4, 2017

EternoGen Aesthetics LLC opens offices at Massachusetts Medical Device Development Center (M2D2)

EternoGen Aesthetics LLC (EA), developer and manufacturer of advanced collagen scaffolds to deliver Bio Dermal Restoration, announced today the opening of new offices within the Massachusetts Medical Device Development Center (M2D2).  The new office will allow the company to be close to their manufacturing site in Massachusetts and to capitalize on the skill base that comes with the dense clustering of similar firms in the region.

Read the press release here.

December 19, 2016

Massachusetts Selected to Partner in Biopharmaceutical Manufacturing Innovation

Today the Baker-Polito Administration is pleased to announce that Massachusetts will be a partner in the nation’s first manufacturing innovation institute in biopharmaceutical manufacturing.

Massachusetts will anchor the northeastern node for the biopharmaceutical manufacturing project, which will be known as the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The NIIMBL project will be led regionally by a consortium of small, medium, and large biopharmaceutical industry partners from across the supply chain, along with the Massachusetts Institute of Technology (MIT), Quincy College, UMass Lowell, UMass Medical School, and the Worcester Polytechnic Institute (WPI).

Read the press release here

December 14, 2016

Forum Promotes Opportunities to Link Life Sciences Industry with Philanthropy in Greater Boston

Leaders of the life science sector convened at The Boston Foundation Tuesday evening to initiate what all insisted would be a long-term conversation aimed at educating the public and the philanthropic sector about where life sciences fit in Greater Boston’s burgeoning innovation economy and educating the life science sector on how best and most practically to participate in philanthropy and give back to their host communities.

Read the press release here.

December 6, 2016

Lexington Medical opens new headquarters in Billerica

Lexington Medical is developing abdominal surgical instruments, with a novel business model designed to substantially lower costs of healthcare delivery. The company was founded by medical device industry veterans with experience in both S&P 500 medical device suppliers as well as innovative technology start-ups. The new 8,000 square feet facility will house Lexington Medical’s 10 employees, with room for future growth.

Read the Press Release Here


Nancy Cadigan, Aide to State Representative Marc Lombardo (R-Billerica), Leon Amariglio, Founder and CEO of Lexington Medical, Travis McCready, President & CEO of the Massachusetts Life Sciences Center, and Kendalle Burlin O’Connell, VP for Member Services & General Counsel at MassBio, celebrate the grand opening of Lexington Medical’s new headquarters in Billerica, Massachusetts

October 27, 2016

Holst Center Launches in North America

Holst Centre, a leading Dutch research institute in the area of flexible electronics and wireless sensing, based in Eindhoven the Netherlands, hosted an introductory event at the Cambridge Innovation Center to announce their expansion into Massachusetts and bolster relationships in North America. The event was supported by the Province of Noord-Brabant, the Netherlands.

Read the press release here »

October 3, 2016

Grand opening ceremony of LEO Science & Tech Hub in Cambridge

Her Royal Highness Crown Princess Mary of Denmark and Danish Minister for Business and Growth Troels Lund Poulsen officially inaugurated the LEO Science & Tech Hub. The Hub aims to catalyze early-stage collaborations in science and technology in order to advance the treatment of skin diseases and is the first of its kind to focus on dermatology in Massachusetts, the world’s leading life science ecosystem.


Photo Caption: From left to right: Her Royal Highness, Crown Princess Mary of Denmark and LEO Pharma President & CEO Gitte Pugholm Aabo celebrate the opening of the LEO Science & Tech Hub at the Cambridge Innovation Center

Read the press release here »

September 28, 2016

ABI-LAB Celebrates its Grand Opening in Natick Massachusetts

ABI-LAB, an accelerator and bioincubator shared laboratory facility that supports startup companies through availability of affordable lab space and innovative pre-clinical services had a grand opening ceremony in Natick, Massachusetts.

Read the Press Release here.


Photo Caption: From left to right, (third from left) MassBio Manager, Member Recruitment Laura Hamilton, State Senator Richard Ross State, Senator Karen Spilka, Gary Kaufman, Managing Partner of ABI-LAB, Dr. Rafael Nir, Managing Partner of ABI-LAB, and MLSC Vice President for Communications & Marketing Angus McQuilken (last from right).


September 23, 2016

Massachusetts Life Sciences Center Announces New Appointees to Board of Directors

The Massachusetts Life Sciences Center (MLSC) announced today that Governor Charlie Baker has appointed Pam Randhawa, Founder and Chief Executive Officer of Empiriko Corporation and Gary Paul Kearney, M.D., past President of the Medical Staff, Chief of Urology, and Vice Chairman of the Department of Surgery at New England Baptist Hospital, to the MLSC Board of Directors.

Read the Press Release here.

September 14, 2016

FDA clears icometrix’ image quantification software to monitor neurological disorders

After opening a subsidiary in the Boston area earlier this year, Belgian health tech company icometrix has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their image quantification software, icobrain. icobrain quantifies key features of clinical MRI brain scans, which enable clinicians to monitor how their patient’s brain changes over time.

Read the press release here »

July 15, 2016

The Massachusetts Life Sciences Center and Massachusetts General Hospital launch the Massachusetts Center for Alzheimer Therapeutics Science (MassCATS)

The Massachusetts Life Sciences Center (MLSC), Massachusetts General Hospital (MGH) and five leading biopharma companies have launched the Massachusetts Center for Alzheimer Therapeutics Science (MassCATS), a unique collaboration among world-class industry and academic researchers working to find therapies for Alzheimer’s disease.  The new Center will be located at MGH.  Industry partners, including AbbVie, Biogen, Janssen Pharmaceuticals, Inc., Merck and Sunovion Pharmaceuticals have committed $1.25 million in Alzheimer’s-related research funding.

Read the press release here

MassCATS photo 1

(left to right).  Massachusetts Assistant Secretary for Economic Development Mike Kennealy, Alzheimer’s advocate and caregiver Brenda Bouchard, Massachusetts Secretary for Housing & Economic Development Jay Ash, Director of MA Alzheimer’s Disease Research Center Brad Hyman, Ph.D., Massachusetts General Hospital President & CEO Peter Slavin, Massachusetts Life Sciences Center General Counsel and VP for Academic & Workforce Programs Beth Nicklas, and Massachusetts Life Sciences Center President & CEO Travis McCready celebrate the launch of the new Massachusetts Center for Alzheimer Therapeutics Science (MassCATS) at Massachusetts General Hospital.
June 29, 2016

Eurofins Lancaster Laboratories expands Northeast footprint; opens first office in Cambridge, Mass.

Eurofins Lancaster Laboratories, a global leader in bio/pharmaceutical laboratory services, announced today the opening of its Northeast office, located in the Cambridge Innovation Center (CIC) in Cambridge, Massachusetts.

Backed by a 55-year successful track record, Eurofins Lancaster Laboratories offers a complete range of CMC Testing Services to support virtual and large bio/pharmaceutical companies and CMOs worldwide, including testing of all starting materials, process intermediates, bulk drug, finished product, and final packaging components through its broad technical expertise in Biochemistry, Molecular & Cell Biology, Virology, Chemistry and Microbiology.

Read the Press Release here

Connect With Us

Facebook LinkedIn Twitter